« POPE 5 Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next

Re: GSK and 23andMe sign agreement to leverage genetic insights for the development of novel medicines 

By: capt_nemo in POPE 5 | Recommend this post (1)
Sun, 13 Jan 19 7:15 AM | 26 view(s)
Boardmark this board | Pope 5
Msg. 20147 of 62138
(This msg. is a reply to 20145 by Riana)

Jump:
Jump to board:
Jump to msg. #

Scary stuff!!!!!!!!!!!!!!!!!




Avatar

Realist - Everybody in America is soft, and hates conflict. The cure for this, both in politics and social life, is the same -- hardihood. Give them raw truth.




» You can also:
- - - - -
The above is a reply to the following message:
GSK and 23andMe sign agreement to leverage genetic insights for the development of novel medicines
By: Riana
in POPE 5
Sun, 13 Jan 19 6:46 AM
Msg. 20145 of 62138

And people wonder why I, as a genealogist, refuse to participate in any of the genealogy DNA projects.

What could possibly go wrong...

GSK and 23andMe today unveiled an exclusive four-year collaboration that will focus on research and development of innovative new medicines and potential cures, using human genetics as the basis for discovery. The collaboration will combine 23andMe’s large-scale genetic resources and advanced data science skills, with the scientific and medical knowledge and commercialisation expertise of GSK. The goal of the collaboration is to gather insights and discover novel drug targets driving disease progression and develop therapies for serious unmet medical needs based on those discoveries.

http://www.gsk.com/en-gb/media/press-releases/gsk-and-23andme-sign-agreement-to-leverage-genetic-insights-for-the-development-of-novel-medicines


« POPE 5 Home | Email msg. | Reply to msg. | Post new | Board info. Previous | Home | Next